Summary
Teradyne, Inc. reported a strong third quarter for fiscal year 2006, demonstrating a significant turnaround from the same period in the prior year. Net revenues grew by 22.3% year-over-year to $359.1 million, driven primarily by a robust increase in Semiconductor Test Systems revenue. This top-line growth, coupled with improved operational efficiencies and a favorable product mix, led to a substantial increase in gross profit, which more than doubled compared to the prior year's third quarter. The company also achieved a significant positive net income of $60.6 million, a marked improvement from a net loss of $35.4 million in the prior year's comparable quarter. This turnaround was supported by effective cost management, including reduced engineering and development expenses as a percentage of revenue, and a substantial gain on the sale of real estate which positively impacted restructuring charges. The company's strong cash generation from operations and a healthy cash balance of over $1.1 billion provide a solid foundation for future investments and shareholder returns, including an authorized $400 million stock repurchase program.
Key Highlights
- 1Net revenues increased by 22.3% to $359.1 million in Q3 2006 compared to Q3 2005, driven by a 23.8% rise in Semiconductor Test Systems revenue.
- 2Gross profit significantly improved, growing from $89.2 million in Q3 2005 to $175.3 million in Q3 2006, with gross margin expanding from 30.4% to 48.8%.
- 3The company achieved a net income of $60.6 million in Q3 2006, a substantial recovery from a net loss of $35.4 million in Q3 2005.
- 4Operating expenses as a percentage of net revenues decreased due to improved efficiency, with Engineering & Development at 14.8% and Selling & Administrative at 20.0% in Q3 2006.
- 5Restructuring activities included a significant gain of $16.6 million on real estate sales in Q3 2006, positively impacting the net restructuring charges.
- 6Cash and cash equivalents and marketable securities stood at $1.17 billion as of October 1, 2006, indicating strong liquidity.
- 7Teradyne initiated a stock repurchase program in July 2006, authorizing up to $400 million for share buybacks.